
BPC-157: Research, Mechanism & Legal Status
What the research says about BPC-157, mechanism of action, preclinical findings, side effects, and current FDA Category 2 legal status. Educational overview from PepScribe.
Read articlePeptides studied for recovery, sleep, growth-hormone pathways, and healthy aging.

What the research says about BPC-157, mechanism of action, preclinical findings, side effects, and current FDA Category 2 legal status. Educational overview from PepScribe.
Read articleWhat the research says about CJC-1295, the long-acting GHRH analog, DAC vs. non-DAC variants, the Teichman 2006 trial, ipamorelin pairings, side effects, and FDA transitional regulatory status.

Does sermorelin work? A clinician-grounded look at the clinical evidence, how sermorelin stimulates growth hormone, who is a candidate, and what realistic outcomes look like under physician supervision.


What is publicly known about Emideltide, an obscure research-stage peptide with very limited published literature, its possible relationship to delta-sleep peptide research, and its FDA transitional regulatory status as of April 2026.

What the research says about Epitalon (Ala-Glu-Asp-Gly), the Khavinson tetrapeptide. Telomerase research, pineal regulation, and FDA Category 2 status.

What the research says about Ipamorelin, a selective ghrelin-receptor agonist and growth-hormone-releasing peptide. Mechanism, Novo Nordisk discovery, comparative GHRP selectivity, and current US regulatory posture.

What the research says about NAD+, how this coenzyme supports cellular energy, DNA repair, and sirtuin activity. Mechanism, current research evidence, and honest limits of human trial data.

NAD therapy uses intravenous or subcutaneous NAD+ to replenish declining cellular cofactor levels. This guide covers the science, administration routes, expected effects, and how clinician-supervised NAD therapy differs from oral supplements.

What the research says about PEG-MGF (Pegylated Mechano Growth Factor), the IGF-1Ec splice variant, satellite cell activation, muscle repair research, safety considerations, and FDA transitional legal status.

What the research says about sermorelin, a GHRH analog that stimulates your body's own growth hormone release. Mechanism, research evidence, side effects, and how it differs from synthetic HGH.

A clinically grounded review of sermorelin benefits — how this growth hormone-releasing peptide works, what the evidence supports for body composition, sleep, and recovery, and who is a realistic candidate.

Sermorelin dosage explained — typical starting doses, how clinicians adjust based on IGF-1 labs and symptom response, injection timing, and why sermorelin dosing differs from other peptides.
Ready when you are
Take a 3-minute assessment and a licensed clinician will recommend the right protocol for you — compounded in the USA by licensed 503A pharmacies.